Apigenin
Research Reliability -
A chamomile-derived flavonoid that binds GABA receptors for calm, sleep-supportive effects with emerging senolytic activity.
Appetite
Mood
Sleep
Apigenin
Description
Apigenin, the primary active flavonoid in chamomile, binds benzodiazepine sites on GABA-A receptors, producing a mild anxiolytic and sleep-supportive effect without the dependency profile of pharmaceutical benzodiazepines — explaining chamomile tea's longstanding reputation as a calming bedtime ritual, just at a more concentrated, standardized dose. Separately, it has emerged in cell-senescence research as having mild senolytic properties, drawing interest from the same longevity community exploring fisetin and quercetin, though this application has far less human data than its sleep-related use. Some men's health forums have raised theoretical concerns about aromatase inhibition at very high doses affecting hormone balance; standard sleep-support doses are well below where this becomes a practical concern.
Effects
First night
calmer and drowsy within 30–60 minutes
Same night
Weeks
How It Feels
Taken at night many feel a gentle calm and easier sleep onset within the hour, essentially a concentrated version of chamomile's effect. The separate longevity angle is not something you feel. Keep to standard sleep doses rather than the very high amounts discussed in that context.
Evidence
Evidence Strength
Animal / preclinical only
Caveats
No human senolytic trials exist for apigenin. Current mechanistic evidence suggests apigenin may be senomorphic (suppressing inflammatory signaling from senescent cells) rather than truly senolytic (killing senescent cells) -- the popular 'senolytic' marketing claim is not supported by the current evidence.
Usage
Commonly Referenced Starting Amount
No established supplement dose
Commonly Referenced Amount
There are no reliable human dosing trials for apigenin as a standalone supplement — what data exists comes from chamomile tea and cell/animal research
Referenced Upper Limit
No upper limit has been established. Worth a direct honesty note: apigenin is often marketed as senolytic (killing aged cells), but the current mechanistic evidence points to it being senomorphic (calming the inflammatory signals aged cells send out) instead — a real but different effect than the marketing claims
Onset
30–60 minutes (sleep); weeks (senolytic/cellular)
Biomarkers to Track
Subjective
(Daily)
Sleep onset time and quality
Anxiety levels (1–10)
Morning grogginess
Objective
(Quarterly)
Sleep tracker (sleep onset latency, deep sleep)
hs-CRP (if tracking senolytic/inflammation angle)
Generally safe at sleep doses, essentially concentrated chamomile. It may interact with sedatives and blood thinners.
Pregnant women, and people on sedatives or blood thinners.
Taking the very high longevity-context doses for sleep, when a standard dose is enough.
Disclaimer
This information is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.
Zhang J et al. (2025). Advanced Science. In vitro / animal study (apigenin and cellular senescence).
MORE SUPPLEMENTS LIKE THIS
